The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Activities

CDDF offers workshops, conferences and webinars that bring stakeholders involved in cancer drug development into a productive dialogue in a neutral, non-competitive space. CDDF holds multiple activities and initiatives in collaboration with regulators from both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) and other regulatory agencies, academic researchers from around the globe, pharmaceutical companies, and patient advocates.

The Cancer Drug Development Forum (CDDF) Spring Conference is a unique annual meeting. This multi-stakeholder, interactive 3-day meeting offers plenary lectures with moderated discussions, including case studies and networking opportunities. In addition to the Spring conference, the CDDF organises workshops to facilitate multi-stakeholder collaboration to address topical issues in the cancer research field.

=

Upcoming meetings

=

Past meetings

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70